When we hear the word ‘cancer,’ we often automatically associate the disease with chemotherapy, a highly recognized and highly aggressive drug used to combat cancer in the body. While chemotherapy is often an effective cancer treatment, it can unfortunately leave someone who endures its severity with several long-term conditions and side effects as a result of the harshness of the drug itself.
But, chemotherapy could possibly move to the back burner when it comes to treating cancer, thanks to “a study testing thousands of medicines in hundreds of cancer cell lines” in labs, says an article from The Good News Network.
“Drugs for diabetes, inflammation, alcoholism—and even for treating arthritis in dogs—can also kill cancer cells in the lab, according to a study by scientists at the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute,” the article explains. “The researchers systematically analyzed thousands of already developed drug compounds and found nearly 50 that have previously unrecognized anti-cancer activity.”
And that’s not all. “The surprising findings, which also revealed novel drug mechanisms and targets, suggest a possible way to accelerate the development of new cancer drugs or repurpose existing drugs to treat cancer.”
With the researcher’s work appearing in the Nature Cancer journal, the study in question is the largest yet to “employ the Broad’s Drug Repurposing Hub, a collection that currently comprises more than 6,000 existing drugs and compounds that are either FDA-approved or have been proven safe in clinical trials (at the time of the study, the Hub contained 4,518 drugs),” the article explains. Further, this study allowed the researchers to screen “the entire collection of mostly non-cancer drugs for their anti-cancer capabilities” for the first time.
The article linked above is reprinted from the Broad Institute; check out the original article for more information pertaining to some darn good news.